Adzynma 1500 IU lyophilized powder for Injection Images
Generic Name: apadamtase alfa, recombinant
This medication has been identified as Adzynma 1500 IU lyophilized powder for Injection. It is supplied by Takeda Pharmaceutical Company Limited.
Adzynma is used in the treatment of Thrombotic Thrombocytopenic Purpura and belongs to the drug class miscellaneous coagulation modifiers. Adzynma 1500 IU lyophilized powder for Injection is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Adzynma
- Generic Name
- apadamtase alfa, recombinant
- Strength
- 1500 IU lyophilized powder for Injection
- Availability
- Prescription only
- Drug Class
- Miscellaneous coagulation modifiers
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Takeda Pharmaceutical Company Limited
- National Drug Code (NDC)
- 64764-0135
More about Adzynma (apadamtase alfa, recombinant)
- Compare alternatives
- Pricing & coupons
- Reviews (1)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous coagulation modifiers
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.